Xponance Inc. Boosts Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Xponance Inc. boosted its holdings in DocuSign, Inc. (NASDAQ:DOCU) by 45.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 51,709 shares of the company’s stock after acquiring an additional 16,249 shares during the quarter. Xponance Inc.’s holdings in DocuSign were worth $4,651,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Intech Investment Management LLC lifted its position in DocuSign by 48.1% during the fourth quarter. Intech Investment Management LLC now owns 164,381 shares of the company’s stock valued at $14,784,000 after purchasing an additional 53,375 shares during the period. Generali Asset Management SPA SGR bought a new position in shares of DocuSign during the 4th quarter valued at $2,127,000. Thrivent Financial for Lutherans boosted its stake in shares of DocuSign by 1.8% in the 4th quarter. Thrivent Financial for Lutherans now owns 2,318,137 shares of the company’s stock worth $208,494,000 after buying an additional 40,825 shares during the last quarter. Primecap Management Co. CA grew its holdings in shares of DocuSign by 17.8% in the fourth quarter. Primecap Management Co. CA now owns 574,530 shares of the company’s stock worth $51,673,000 after acquiring an additional 86,690 shares during the period. Finally, Signaturefd LLC increased its position in DocuSign by 12.2% during the fourth quarter. Signaturefd LLC now owns 1,686 shares of the company’s stock valued at $152,000 after acquiring an additional 183 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.

Insider Activity

In related news, CEO Allan C. Thygesen sold 40,000 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $90.04, for a total transaction of $3,601,600.00. Following the completion of the transaction, the chief executive officer now directly owns 156,050 shares of the company’s stock, valued at approximately $14,050,742. This represents a 20.40 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Blake Jeffrey Grayson sold 16,111 shares of DocuSign stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $83.20, for a total value of $1,340,435.20. Following the completion of the sale, the chief financial officer now directly owns 93,960 shares in the company, valued at approximately $7,817,472. The trade was a 14.64 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 97,851 shares of company stock worth $8,579,369 over the last 90 days. Corporate insiders own 1.66% of the company’s stock.

DocuSign Trading Down 0.6 %

NASDAQ DOCU opened at $85.11 on Friday. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86. The stock has a market cap of $17.19 billion, a PE ratio of 17.55, a P/E/G ratio of 6.94 and a beta of 1.02. The stock’s 50 day moving average is $87.58 and its 200 day moving average is $79.95.

DocuSign (NASDAQ:DOCU) last released its earnings results on Thursday, March 13th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.84 by $0.02. The firm had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The company’s quarterly revenue was up 9.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.76 earnings per share. On average, analysts forecast that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on DOCU. UBS Group dropped their target price on DocuSign from $100.00 to $90.00 and set a “neutral” rating on the stock in a research report on Friday, March 14th. Wells Fargo & Company raised their price objective on shares of DocuSign from $70.00 to $73.00 and gave the stock an “underweight” rating in a report on Friday, March 14th. JMP Securities reaffirmed a “market outperform” rating and set a $124.00 target price on shares of DocuSign in a report on Tuesday, January 7th. Bank of America dropped their price target on shares of DocuSign from $112.00 to $98.00 and set a “neutral” rating on the stock in a research note on Friday, March 14th. Finally, Piper Sandler upped their price objective on DocuSign from $60.00 to $90.00 and gave the stock a “neutral” rating in a research note on Friday, December 6th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $95.00.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.